Geoffrey Alexander Sonn, MD
Urology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Community Hospital of the Monterey Peninsula · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sonn’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A96537 · Current
Licensed to practise in California · since 2006 · expires 2028-05-31 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Community Hospital of the Monterey Peninsula
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.48 (1.22 to 1.74) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.12 (1.69 to 4.56) · 1,095 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 19.24 (14.17 to 24.3) · 1,118 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 9.62 (6.42 to 12.82) · 1,086 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.39 to 2.16) · 1,873 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.2 (110.65 to 205.75) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 686 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 1,072 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,300 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.11 to 0.48) · 10,234 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.46) · 10,572 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (1.47 to 5.04) · 2,617 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.04 to 3.7) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.21 (0.75 to 3.66) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.06 to 1.17) · 8,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 156 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.732 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 152 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 625 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.3 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.2 · 749 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 1,074 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 850 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.7 to 5.8) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.4 to 17.4) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.9 to 18.6) · 711 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$114,430
Medicare paid this office $114,430 for 417 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 21 | $22,268 | $1,060 |
| Biopsy of prostate gland | 124 | $13,502 | $109 |
| High-intensity ultrasound destruction of cancerous tissue in prostate gland, accessed through rectum using ultrasound guidance | 14 | $13,039 | $869 |
| Return visit (30+ min) | 75 | $9,016 | $116 |
| Long return visit (40+ min) | 54 | $8,562 | $153 |
See all 12 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 21 | $22,268 | $1,060 |
| Biopsy of prostate gland | 124 | $13,502 | $109 |
| High-intensity ultrasound destruction of cancerous tissue in prostate gland, accessed through rectum using ultrasound guidance | 14 | $13,039 | $869 |
| Return visit (30+ min) | 75 | $9,016 | $116 |
| Long return visit (40+ min) | 54 | $8,562 | $153 |
| New patient visit (60+ min) | 43 | $8,369 | $195 |
| New patient visit (45+ min) | 48 | $6,523 | $136 |
| Short return visit (20+ min) | 59 | $4,799 | $77 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 14 | $4,149 | $296 |
| New patient visit (45+ min) | 25 | $2,603 | $104 |
| Ultrasound scan of pelvic region through rectum | 41 | $1,175 | $29 |
| Ultrasonic guidance for needle placement | 21 | $505 | $24 |
Procedures Medicare counted
| Prostate resection | 23 | More than 84% of doctors who do this |
Who their Medicare patients are
417 Original Medicare patients in 2024. Average age 73 · Women 4% · Also on Medicaid 6% · Health risk score 0.84. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: Cancer 75% · High blood pressure 61% · Coronary heart disease 26% · Chronic kidney disease 19% · Diabetes 18% · Atrial fibrillation 18% · Heart failure 9% · Depression 6% · COPD 4% · Stroke 4%.
The office billed $1,211,329, Medicare allowed $150,598 and paid $114,430; for 637 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 417 | 637 | 73 | 0.84 | $1,211,329 | $114,430 |
| 2023 | 382 | 649 | 73 | 0.78 | $1,480,816 | $101,666 |
| 2022 | 329 | 596 | 72 | 0.93 | $1,415,453 | $100,643 |
| 2021 | 336 | 715 | 73 | 0.99 | $1,979,497 | $128,219 |
| 2020 | 271 | 553 | 72 | 1.13 | $914,990 | $82,837 |
| 2019 | 281 | 617 | 72 | 1.16 | $683,977 | $93,918 |
| 2018 | 246 | 530 | 71 | 1.10 | $607,011 | $78,576 |
| 2017 | 271 | 620 | 73 | 1.14 | $777,498 | $95,514 |
| 2016 | 269 | 625 | 72 | 1.10 | $711,509 | $94,524 |
| 2015 | 256 | 563 | 71 | 1.42 | $588,760 | $80,683 |
| 2014 | 187 | 374 | 71 | 1.54 | $531,181 | $72,280 |
| 2013 | 60 | 70 | 70 | 2.52 | $68,316 | $11,411 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 25 | $27,139 | $1,086 |
| High-intensity ultrasound destruction of cancerous tissue in prostate gland, accessed through rectum using ultrasound guidance | 14 | $12,576 | $898 |
| Biopsy of prostate gland | 129 | $12,439 | $96 |
| New patient visit (60+ min) | 31 | $5,154 | $166 |
| New patient visit (45+ min) | 45 | $4,570 | $102 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 15 | $4,553 | $304 |
| Return visit (30+ min) | 46 | $3,737 | $78 |
| Long return visit (40+ min) | 29 | $3,522 | $121 |
| Ultrasonic guidance for needle placement | 97 | $2,110 | $22 |
| Short return visit (20+ min) | 39 | $2,016 | $52 |
| Long return visit (40+ min) | 12 | $1,729 | $133 |
| New patient visit (60+ min) | 12 | $1,685 | $140 |
| New patient visit (45+ min) | 15 | $1,575 | $105 |
| Ultrasound scan of pelvic region through rectum | 57 | $1,526 | $27 |
| Return visit (30+ min) | 17 | $1,341 | $79 |
| Short return visit (20+ min) | 11 | $562 | $51 |
2022: 13 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 18 | $23,519 | $1,307 |
| Biopsy of prostate gland | 112 | $11,815 | $105 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 15 | $4,546 | $303 |
| New patient visit (60+ min) | 31 | $4,508 | $145 |
| New patient visit (45+ min) | 32 | $3,968 | $124 |
| Long return visit (40+ min) | 30 | $3,903 | $130 |
| Return visit (30+ min) | 42 | $2,775 | $66 |
| Ultrasonic guidance for needle placement | 100 | $2,545 | $25 |
| Short return visit (20+ min) | 36 | $1,891 | $50 |
| New patient visit (45+ min) | 13 | $1,585 | $122 |
| Ultrasound scan of pelvic region through rectum | 51 | $1,280 | $25 |
| Return visit (30+ min) | 12 | $997 | $83 |
| New patient visit (30+ min) | 11 | $609 | $55 |
2021: 18 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 25 | $33,374 | $1,335 |
| High-intensity ultrasound destruction of cancerous tissue in prostate gland, accessed through rectum using ultrasound guidance | 18 | $16,452 | $914 |
| Biopsy of prostate gland | 118 | $13,346 | $113 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 23 | $7,043 | $306 |
| New patient visit (60+ min) | 31 | $4,901 | $158 |
| Long return visit (40+ min) | 34 | $4,418 | $126 |
| New patient visit (45+ min) | 30 | $3,637 | $121 |
| Ultrasound scan of pelvic region through rectum | 118 | $3,495 | $30 |
| Ultrasonic guidance for needle placement | 113 | $3,164 | $28 |
| New patient visit (60+ min) | 19 | $3,102 | $163 |
| Long return visit (40+ min) | 17 | $2,263 | $133 |
| Return visit (30+ min) | 27 | $2,228 | $83 |
| Short return visit (20+ min) | 32 | $1,673 | $51 |
| New patient visit (45+ min) | 13 | $1,643 | $126 |
| New patient visit (30+ min) | 19 | $1,151 | $61 |
| Diagnostic exam of bladder and urethra using an endoscope | 13 | $997 | $71 |
| Return visit (30+ min) | 12 | $788 | $61 |
| Short return visit (20+ min) | 11 | $691 | $63 |
2020: 13 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 22 | $30,168 | $1,371 |
| Biopsy of prostate gland | 89 | $9,365 | $105 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 21 | $6,368 | $303 |
| New patient visit (45+ min) | 44 | $4,729 | $107 |
| Ultrasonic guidance for needle placement | 89 | $2,576 | $29 |
| New patient visit (45+ min) | 22 | $2,517 | $114 |
| Ultrasound scan of pelvic region through rectum | 86 | $2,437 | $28 |
| Return visit (30+ min) | 25 | $1,846 | $68 |
| Long return visit (40+ min) | 14 | $1,452 | $97 |
| Long return visit (40+ min) | 13 | $1,354 | $97 |
| Short return visit (20+ min) | 24 | $1,002 | $39 |
| Return visit (30+ min) | 14 | $981 | $65 |
| New patient visit (30+ min) | 15 | $894 | $60 |
2019: 12 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 19 | $25,081 | $1,320 |
| Biopsy of prostate gland | 102 | $10,838 | $105 |
| New patient visit (45+ min) | 61 | $6,976 | $114 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 16 | $4,749 | $297 |
| Long return visit (40+ min) | 33 | $2,992 | $91 |
| Ultrasonic guidance for needle placement | 101 | $2,962 | $29 |
| Ultrasound scan of pelvic region through rectum | 100 | $2,825 | $28 |
| New patient visit (45+ min) | 20 | $1,866 | $93 |
| Return visit (30+ min) | 23 | $1,507 | $66 |
| New patient visit (30+ min) | 17 | $1,035 | $61 |
| Short return visit (20+ min) | 19 | $882 | $44 |
| Diagnostic exam of bladder and urethra using an endoscope | 11 | $705 | $64 |
2018: 14 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 14 | $18,413 | $1,315 |
| Biopsy of prostate gland | 94 | $9,927 | $104 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 14 | $4,231 | $302 |
| Suture suspension of urethra to control leakage using an endoscope | 12 | $4,111 | $343 |
| New patient visit (45+ min) | 39 | $4,107 | $105 |
| Ultrasonic guidance for needle placement | 94 | $2,762 | $29 |
| Ultrasound scan of pelvic region through rectum | 88 | $2,526 | $28 |
| New patient visit (45+ min) | 22 | $2,421 | $110 |
| Long return visit (40+ min) | 18 | $1,696 | $94 |
| Return visit (30+ min) | 23 | $1,531 | $67 |
| New patient visit (60+ min) | 12 | $1,519 | $127 |
| Diagnostic exam of bladder and urethra using an endoscope | 15 | $1,045 | $65 |
| Return visit (30+ min) | 11 | $694 | $63 |
| Short return visit (20+ min) | 13 | $553 | $39 |
2017: 11 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 18 | $23,545 | $1,308 |
| Biopsy of prostate gland | 110 | $11,932 | $108 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 18 | $5,436 | $302 |
| New patient visit (45+ min) | 48 | $5,212 | $109 |
| Ultrasonic guidance for needle placement | 110 | $3,159 | $29 |
| Ultrasound scan of pelvic region through rectum | 109 | $3,135 | $29 |
| Long return visit (40+ min) | 22 | $2,107 | $88 |
| Diagnostic exam of bladder and urethra using an endoscope | 20 | $1,772 | $74 |
| New patient visit (45+ min) | 13 | $1,420 | $109 |
| Short return visit (20+ min) | 27 | $1,014 | $36 |
| Return visit (30+ min) | 14 | $846 | $56 |
2016: 14 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 16 | $20,298 | $1,269 |
| Removal of kidney and lymph nodes using an endoscope | 11 | $12,554 | $1,141 |
| Biopsy of prostate gland | 102 | $11,588 | $114 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 16 | $4,597 | $287 |
| New patient visit (45+ min) | 34 | $3,773 | $111 |
| Ultrasound scan of pelvic region through rectum | 102 | $3,094 | $30 |
| Ultrasonic guidance for needle placement | 102 | $3,022 | $30 |
| Diagnostic exam of bladder and urethra using an endoscope | 18 | $2,604 | $100 |
| Long return visit (40+ min) | 20 | $1,982 | $99 |
| New patient visit (30+ min) | 35 | $1,965 | $56 |
| Return visit (30+ min) | 20 | $1,541 | $67 |
| Short return visit (20+ min) | 32 | $1,246 | $36 |
| New patient visit (45+ min) | 11 | $1,153 | $105 |
| Short return visit | 11 | $185 | $14 |
2015: 11 services
| Biopsy of prostate gland | 87 | $9,765 | $112 |
| New patient visit (45+ min) | 44 | $4,933 | $112 |
| Diagnostic exam of bladder and urethra using an endoscope | 20 | $3,098 | $100 |
| Ultrasound scan of pelvic region through rectum | 88 | $2,654 | $30 |
| Ultrasonic guidance for needle placement | 87 | $2,580 | $30 |
| Short return visit (20+ min) | 44 | $2,131 | $38 |
| Insertion of stent in ureter using an endoscope | 14 | $1,686 | $99 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 13 | $1,675 | $129 |
| Return visit (30+ min) | 23 | $1,472 | $64 |
| New patient visit (30+ min) | 23 | $1,426 | $62 |
| Long return visit (40+ min) | 12 | $1,092 | $91 |
2014: 10 services
| New patient visit (45+ min) | 57 | $6,470 | $114 |
| Biopsy of prostate gland | 30 | $3,741 | $125 |
| Diagnostic exam of bladder and urethra using an endoscope | 22 | $2,733 | $101 |
| Short return visit (20+ min) | 41 | $1,991 | $44 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 13 | $1,761 | $135 |
| Return visit (30+ min) | 24 | $1,678 | $70 |
| Insertion of stent in ureter using an endoscope | 12 | $1,678 | $129 |
| New patient visit (30+ min) | 24 | $1,484 | $62 |
| Ultrasound scan of pelvic region through rectum | 30 | $917 | $31 |
| Ultrasonic guidance for needle placement | 30 | $899 | $30 |
2013: 2 services
| New patient visit (30+ min) | 12 | $791 | $66 |
| Short return visit (20+ min) | 12 | $526 | $44 |
Drugs they prescribed that Part D paid
$1,238
Pharmacies billed $1,238 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 29) in 2024. Too few prescriptions to compare fairly with other clinicians.
28 generic and fewer than 11 brand-name prescriptions · $1,238 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tamsulosin | 18 | $451 | $25 |
Year by year
| 2024 | 29 | 11 | 0% (0) | None | $1,238 |
| 2023 | 15 | None | 0% (0) | 0% | $370 |
| 2022 | 20 | 12 | 0% (0) | None | $1,704 |
| 2021 | 42 | 22 | 0% (0) | None | $3,372 |
| 2020 | 50 | 26 | None | None | $2,445 |
| 2019 | 23 | 13 | 0% (0) | None | $2,366 |
| 2018 | 55 | 26 | 0% (0) | None | $1,360 |
| 2017 | 52 | 31 | 0% (0) | None | $578 |
| 2016 | 72 | 30 | None | None | $4,407 |
| 2015 | 115 | 42 | None | None | $3,943 |
| 2014 | 39 | 21 | None | None | $1,493 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Tamsulosin | 12 | $242 | $20 |
2021: 1 drug
| Tamsulosin | 13 | $252 | $19 |
2020: 1 drug
| Finasteride | 13 | $206 | $16 |
2018: 1 drug
| Tamsulosin | 16 | $358 | $22 |
2017: 2 drugs
| Tamsulosin | 12 | $204 | $17 |
| Ciprofloxacin | 13 | $47 | $4 |
2016: 2 drugs
| Tamsulosin | 15 | $351 | $23 |
| Finasteride | 13 | $116 | $9 |
2015: 3 drugs
| Tamsulosin | 35 | $781 | $22 |
| Finasteride | 24 | $234 | $10 |
| Ciprofloxacin | 15 | $66 | $4 |
Money from drug and device companies
$14 in 2025
| 2025 | 1 | 1 | None | $14 |
| 2024 | 2 | 4 | None | $883 |
| 2023 | 3 | 3 | $505 | $568 |
| 2022 | 1 | 1 | None | $171 |
| 2021 | 1 | 2 | $2,800 | $2,800 |
| 2019 | 1 | 1 | $1,400 | $1,400 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Profound Medical | Tulsa-Pro | $14 | 1 payment
|
See the published payment
| Profound Medical | Meals · 2025-04-22 | Tulsa-Pro | $14 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $883
| Edap Technomed | None | $783 | 3 payments
|
| Koelis | Trinity | $100 | 1 payment
|
2023: $568
| Ethicon | None | $505 | 1 payment
|
| Clinical Laserthermia Systems Americas | Mobile Laser Unit | $37 | 1 payment
|
| Profound Medical | Tulsa-Pro | $26 | 1 payment
|
2022: $171
| Edap Technomed | None | $171 | 1 payment
|
2021: $2,800
| Ethicon | Monarch Platform | $2,800 | 2 payments
|
2019: $1,400
| Ethicon | Monarch | $1,400 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| InSightec,LTD · Pca003, Pd006 · 2019 | Their institution | $224,047 |
| InSightec,LTD · Nd001, Uf031,Pca003, Pd006, · 2019 | Their institution | $85,911 |
| InSightec,LTD · Ep001,Pca003, Pca003ca · 2020 | Their institution | $80,525 |
| InSightec,LTD · 2020 | Their institution | $57,263 |
| InSightec,LTD · Nd001, Pca003 · 2019 | Their institution | $40,239 |
| InSightec,LTD · Pca003, Pd006 · 2020 | Their institution | $38,508 |
| InSightec,LTD · Pd006,Pca003, Pca003ca · 2020 | Their institution | $27,528 |
| InSightec,LTD · 2019 | Their institution | $26,907 |
| Insightec,LTD · Exablate · 2021 | Their institution | $23,091 |
| InSightec,LTD · Pca003ca · 2020 | Their institution | $17,984 |
| InSightec,LTD · Pca003, Uf036, Et002 · 2019 | Their institution | $17,521 |
| InSightec,LTD · Pd006, Pca003 · 2019 | Their institution | $6,295 |
| InSightec,LTD · Treatments - Pca003ca · 2022 | Their institution | $3,444 |
| InSightec,LTD · Treatments - Pca003ca · 2023 | Their institution | $3,328 |
| InSightec,LTD · Study Closeout Fee- Pca003 · 2022 | Their institution | $1,630 |
| InSightec,LTD · Pca003ca-Fees · 2022 | Their institution | $896 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1275720351
- Licence
- CA A96537California A96537: Current · expires 2028-05-31
- Trained
- University of California, Geffen School of Medicine, 2005
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X); Surgery (208600000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-10-02
- NPI last updated
- 2026-03-18
- NPI record certified
- 2026-03-18
This is when the NPI record was last certified, not a medical board exam.